Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
May 27 2021 - 7:00AM
Business Wire
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced
that Steve Hoerter, President and Chief Executive Officer, will
participate in fireside chats at the following investor
conferences:
- Jefferies Virtual Healthcare Conference on June 3, 2021 at 1:30
PM ET
- JMP Securities Life Sciences Conference on June 16, 2021 at
4:00 PM ET
A live webcast of both events will be available on the “Events
and Presentations” page in the “Investors” section of the Company’s
website at https://investors.deciphera.com/events-presentations. A
replay of both webcasts will be archived on the Company’s website
for 90 days following the presentation.
About Deciphera Pharmaceuticals
Deciphera is a biopharmaceutical company focused on discovering,
developing and commercializing important new medicines to improve
the lives of people with cancer. We are leveraging our proprietary
switch-control kinase inhibitor platform and deep expertise in
kinase biology to develop a broad portfolio of innovative
medicines. In addition to advancing multiple product candidates
from our platform in clinical studies, QINLOCK® is Deciphera’s
FDA-approved switch-control kinase inhibitor for the treatment of
fourth-line gastrointestinal stromal tumors. For more information,
visit https://www.deciphera.com/ or follow us on LinkedIn and
Twitter (@Deciphera).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210527005257/en/
Investor Relations: Jen Robinson Deciphera
Pharmaceuticals, Inc. jrobinson@deciphera.com 781-906-1112
Media: David Rosen Argot Partners
David.Rosen@argotpartners.com 212-600-1902
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
From Jul 2023 to Jul 2024